Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Bellerophon Therapeutics, Inc. (BLPH)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
7 Jun 2023
Puissance Life Science Opportunities Fund VI
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
1,076,841
-11%
134,421
$0.83
$111,569.43
SELL
18 May 2023
Puissance Life Science Opportunities Fund VI
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
1,211,262
-31%
560,000
$9.46
$5,297,600.00
SELL
18 May 2023
Kim Bobae
VP Reg. Affairs & Quality, Officer
Bellerophon Therapeutics, Inc.
(BLPH)
1,723
-84%
9,455
$10.00
$94,550.00
SELL
18 Mar 2021
New Mountain Investments II, LLC
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
609,231
-39%
400,000
$5.48
$2,192,000.00
BUY
10 Sep 2020
FARES Wassim
Chief Medical Officer, Officer
Bellerophon Therapeutics, Inc.
(BLPH)
4,000
+100%
4,000
$10.18
$40,708.00
BUY
5 Jun 2020
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
60,913
+14%
7,586
$12.77
$96,896.06
BUY
21 Nov 2019
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
592,922
+0%
562.867
$5.76
$3,241.16
SELL
24 Oct 2019
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,435,173
-1%
72,923.14
$7.20
$524,957.25
SELL
24 Oct 2019
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,435,173
-1%
72,923.14
$7.20
$524,957.25
BUY
12 Jun 2019
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
584,479
+0%
3,333.334
$9.57
$31,905.00
BUY
22 May 2019
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
534,479
+0%
1,833.333
$9.02
$16,533.00
BUY
21 May 2019
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
506,979
+0%
2,885.334
$9.14
$26,370.50
BUY
21 May 2019
Peacock Jonathan M
Director
Bellerophon Therapeutics, Inc.
(BLPH)
1,875,920
+0%
1,333.333
$9.15
$12,198.00
BUY
21 May 2019
Tenenbaum Fabian
Chief Executive Officer, Director, Officer
Bellerophon Therapeutics, Inc.
(BLPH)
484,282
+0%
333.333
$8.93
$2,975.00
BUY
25 Jan 2019
Amin Naseem
Director
Bellerophon Therapeutics, Inc.
(BLPH)
1,818,867
+2%
38,095.27
$10.50
$400,000.28
BUY
25 Jan 2019
Wang Theodore T
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
463,699
+6%
30,000.002
$10.50
$315,000.00
BUY
25 Jan 2019
Peacock Jonathan M
Director
Bellerophon Therapeutics, Inc.
(BLPH)
1,855,920
+2%
47,619.07
$10.50
$500,000.20
BUY
23 Jan 2019
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,529,020
+0%
9,523.801
$10.50
$99,999.90
BUY
23 Jan 2019
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,529,020
+0%
9,523.801
$10.50
$99,999.90
BUY
13 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,386,163
+0%
14,000.001
$18.03
$252,354.00
BUY
13 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,386,163
+0%
14,000.001
$18.03
$252,354.00
BUY
10 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,176,163
+0%
31,666.668
$17.63
$558,392.50
BUY
10 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
7,176,163
+0%
31,666.668
$17.63
$558,392.50
BUY
5 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,701,163
+0%
10,666.667
$12.95
$138,162.00
BUY
5 Sep 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,701,163
+0%
10,666.667
$12.95
$138,162.00
BUY
14 Aug 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,541,163
+0%
35,291.336
$9.72
$342,879.06
BUY
14 Aug 2018
VENROCK ASSOCIATES IV L P
10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
6,541,163
+0%
35,291.336
$9.72
$342,879.06
BUY
9 Dec 2016
Luehring Jens
Director, 10% Owner
Bellerophon Therapeutics, Inc.
(BLPH)
39,860
+3%
1,333.333
$8.40
$11,200.00
BUY
17 May 2016
Peacock Jonathan M
President and CEO, Director, Officer
Bellerophon Therapeutics, Inc.
(BLPH)
222,702
+0%
333.333
$20.52
$6,841.50
Home